Cardioprotection by adenosine: is it a question of effective dose, timing, or the target compartment?
Vinten-Johansen
J
J
Hammon
J W
JW
D000241:Adenosine / Q000008:administration & dosage / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D017682:Myocardial Stunning / Q000517:prevention & control*; D018047:Receptors, Purinergic P1 / Q000502:physiology
D002317:Cardiovascular Agents; D018047:Receptors, Purinergic P1; D000241:Adenosine